Medtech industry, lawmakers concerned about FDA's 510(k) proposals
This article was originally published in RAJ Devices
The cumulative effect of preliminary proposals by the US Food and Drug Administration to overhaul its premarket notification, or 510(k), programme for clearing medical devices could adversely affect the agency's ability to effectively carry out "mission-critical" functions, including timely reviews, industry has warned1,2.
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.